1. Home
  2. GLBS vs INTS Comparison

GLBS vs INTS Comparison

Compare GLBS & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

HOLD

Current Price

$1.75

Market Cap

21.9M

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.52

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBS
INTS
Founded
2006
2012
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
24.0M
IPO Year
2007
2023

Fundamental Metrics

Financial Performance
Metric
GLBS
INTS
Price
$1.75
$0.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$3.00
$4.33
AVG Volume (30 Days)
278.3K
3.9M
Earning Date
11-28-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,444,000.00
N/A
Revenue This Year
$16.13
N/A
Revenue Next Year
$20.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.49
N/A
52 Week Low
$0.99
$0.19
52 Week High
$1.99
$3.17

Technical Indicators

Market Signals
Indicator
GLBS
INTS
Relative Strength Index (RSI) 68.40 56.47
Support Level $1.72 $0.46
Resistance Level $1.99 $0.54
Average True Range (ATR) 0.14 0.04
MACD 0.05 0.01
Stochastic Oscillator 70.24 84.23

Price Performance

Historical Comparison
GLBS
INTS

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: